170 related articles for article (PubMed ID: 38279513)
41. Dual mTORC1/2 inhibition induces anti-proliferative effect in NF1-associated plexiform neurofibroma and malignant peripheral nerve sheath tumor cells.
Varin J; Poulain L; Hivelin M; Nusbaum P; Hubas A; Laurendeau I; Lantieri L; Wolkenstein P; Vidaud M; Pasmant E; Chapuis N; Parfait B
Oncotarget; 2016 Jun; 7(24):35753-35767. PubMed ID: 26840085
[TBL] [Abstract][Full Text] [Related]
42. Malignant peripheral nerve sheath tumor of tongue: a case report.
Liu Y; Wu D; Lun X; Dai W
Hua Xi Kou Qiang Yi Xue Za Zhi; 2023 Jun; 41(3):361-364. PubMed ID: 37277804
[TBL] [Abstract][Full Text] [Related]
43. The implications of intradural extension in paraspinal malignant peripheral nerve sheath tumors: effects on central nervous system metastases and overall survival.
Gilder HE; Puffer RC; Bydon M; Spinner RJ
J Neurosurg Spine; 2018 Dec; 29(6):725-728. PubMed ID: 30239270
[TBL] [Abstract][Full Text] [Related]
44. Methylation-based classification of benign and malignant peripheral nerve sheath tumors.
Röhrich M; Koelsche C; Schrimpf D; Capper D; Sahm F; Kratz A; Reuss J; Hovestadt V; Jones DT; Bewerunge-Hudler M; Becker A; Weis J; Mawrin C; Mittelbronn M; Perry A; Mautner VF; Mechtersheimer G; Hartmann C; Okuducu AF; Arp M; Seiz-Rosenhagen M; Hänggi D; Heim S; Paulus W; Schittenhelm J; Ahmadi R; Herold-Mende C; Unterberg A; Pfister SM; von Deimling A; Reuss DE
Acta Neuropathol; 2016 Jun; 131(6):877-87. PubMed ID: 26857854
[TBL] [Abstract][Full Text] [Related]
45. S100-negative epithelioid malignant peripheral nerve sheath tumor with possible perineurial differentiation.
Yamashita K; Funauchi Y; Hayakawa K; Ae K; Matsumoto S; Ikuta K; Nishida Y; Ueno T; Shimoyama Y; Hiruta N; Machinami R; Kawachi H; Takeuchi K
Virchows Arch; 2022 Jun; 480(6):1269-1275. PubMed ID: 34635937
[TBL] [Abstract][Full Text] [Related]
46. Microarray-based copy number analysis of neurofibromatosis type-1 (NF1)-associated malignant peripheral nerve sheath tumors reveals a role for Rho-GTPase pathway genes in NF1 tumorigenesis.
Upadhyaya M; Spurlock G; Thomas L; Thomas NS; Richards M; Mautner VF; Cooper DN; Guha A; Yan J
Hum Mutat; 2012 Apr; 33(4):763-76. PubMed ID: 22331697
[TBL] [Abstract][Full Text] [Related]
47. TYK2 promotes malignant peripheral nerve sheath tumor progression through inhibition of cell death.
Qin W; Godec A; Zhang X; Zhu C; Shao J; Tao Y; Bu X; Hirbe AC
Cancer Med; 2019 Sep; 8(11):5232-5241. PubMed ID: 31278855
[TBL] [Abstract][Full Text] [Related]
48. Malignant peripheral nerve sheath tumor invasion requires aberrantly expressed EGF receptors and is variably enhanced by multiple EGF family ligands.
Byer SJ; Brossier NM; Peavler LT; Eckert JM; Watkins S; Roth KA; Carroll SL
J Neuropathol Exp Neurol; 2013 Mar; 72(3):219-33. PubMed ID: 23399900
[TBL] [Abstract][Full Text] [Related]
49. Malignant peripheral nerve sheath tumors with high and low Ras-GTP are permissive for oncolytic herpes simplex virus mutants.
Mahller YY; Rangwala F; Ratner N; Cripe TP
Pediatr Blood Cancer; 2006 Jun; 46(7):745-54. PubMed ID: 16124003
[TBL] [Abstract][Full Text] [Related]
50. Gastric Malignant Peripheral Nerve Sheath Tumor in Type 1 Neurofibromatosis.
Hwang HS; Jeong YJ; Nam KH; Oh SJ; Park YE
Korean J Gastroenterol; 2022 Jun; 79(6):265-269. PubMed ID: 35746841
[TBL] [Abstract][Full Text] [Related]
51. Malignant Peripheral Nerve Sheath Tumor in the Nasal Cavity of a Neonate: A Case Report.
Chi X; Wang Y; Yang H; Xing C; Gan J; Yang S; Liu GS; Han SS; Nie C; Gao H
Ear Nose Throat J; 2023 Oct; 102(10):NP527-NP533. PubMed ID: 34134529
[TBL] [Abstract][Full Text] [Related]
52. Transposon Mutagenesis-Guided CRISPR/Cas9 Screening Strongly Implicates Dysregulation of Hippo/YAP Signaling in Malignant Peripheral Nerve Sheath Tumor Development.
Vélez-Reyes GL; Koes N; Ryu JH; Kaufmann G; Berner M; Weg MT; Wolf NK; Rathe SK; Ratner N; Moriarity BS; Largaespada DA
Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33808166
[TBL] [Abstract][Full Text] [Related]
53. Malignant peripheral nerve sheath tumors of the eighth cranial nerve arising without prior irradiation.
Carlson ML; Jacob JT; Habermann EB; Glasgow AE; Raghunathan A; Link MJ
J Neurosurg; 2016 Nov; 125(5):1120-1129. PubMed ID: 26745487
[TBL] [Abstract][Full Text] [Related]
54. Malignant peripheral nerve sheath tumor of intracranial nerve: a case series review.
Ziadi A; Saliba I
Auris Nasus Larynx; 2010 Oct; 37(5):539-45. PubMed ID: 20399579
[TBL] [Abstract][Full Text] [Related]
55. Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.
Mohan P; Castellsague J; Jiang J; Allen K; Chen H; Nemirovsky O; Spyra M; Hu K; Kluwe L; Pujana MA; Villanueva A; Mautner VF; Keats JJ; Dunn SE; Lazaro C; Maxwell CA
Oncotarget; 2013 Jan; 4(1):80-93. PubMed ID: 23328114
[TBL] [Abstract][Full Text] [Related]
56. A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.
Fernández-Rodríguez J; Creus-Bachiller E; Zhang X; Martínez-Iniesta M; Ortega-Bertran S; Guha R; Thomas CJ; Wallace MR; Romagosa C; Salazar-Huayna L; Reilly KM; Blakely JO; Serra-Musach J; Pujana MA; Serra E; Villanueva A; Ferrer M; Lázaro C
Mol Cancer Ther; 2022 Jul; 21(7):1246-1258. PubMed ID: 35511749
[TBL] [Abstract][Full Text] [Related]
57. Integrating analysis of proteome profile and drug screening identifies therapeutic potential of MET pathway for the treatment of malignant peripheral nerve sheath tumor.
Tsuchiya R; Yoshimatsu Y; Noguchi R; Sin Y; Ono T; Akiyama T; Kosako H; Yoshida A; Ohtori S; Kawai A; Kondo T
Expert Rev Proteomics; 2023; 20(4-6):109-119. PubMed ID: 37229542
[TBL] [Abstract][Full Text] [Related]
58. Targeted Inhibition of the Dual Specificity Phosphatases DUSP1 and DUSP6 Suppress MPNST Growth via JNK.
Ramkissoon A; Chaney KE; Milewski D; Williams KB; Williams RL; Choi K; Miller A; Kalin TV; Pressey JG; Szabo S; Azam M; Largaespada DA; Ratner N
Clin Cancer Res; 2019 Jul; 25(13):4117-4127. PubMed ID: 30936125
[TBL] [Abstract][Full Text] [Related]
59. Expression and function of somatostatin receptors in peripheral nerve sheath tumors.
Mawrin C; Schulz S; Hellwig-Patyk A; Kirches E; Roessner A; Lendeckel U; Firsching R; Vorwerk CK; Keilhoff G; Dietzmann K; Grimm K; Lindberg G; Gutmann DH; Scheithauer BW; Perry A
J Neuropathol Exp Neurol; 2005 Dec; 64(12):1080-8. PubMed ID: 16319718
[TBL] [Abstract][Full Text] [Related]
60. Perineurial malignant peripheral nerve sheath tumor (MPNST): a clinicopathologic, immunohistochemical, and ultrastructural study of seven cases.
Hirose T; Scheithauer BW; Sano T
Am J Surg Pathol; 1998 Nov; 22(11):1368-78. PubMed ID: 9808129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
